Jerome Bourgault
Quebec, QC G1V4G5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 13, 2025
Associations between circulating amino acids and metabolic dysfunction-associated steatotic liver disease in individuals living with severe obesity.
Journal: Physiological reports
Published: October 17, 2024
Loss-of-Function in APOC3 and Protection Against Aortic Valve Disease.
Journal: Journal of the American College of Cardiology
Published: June 18, 2024
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.
Journal: Cardiovascular research
Published: June 14, 2024
Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
Journal: Atherosclerosis
Published: February 14, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targets.
Journal: European heart journal open
Published: December 13, 2023
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
Journal: European heart journal
Published: May 30, 2023
Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease.
Journal: iScience
Published: April 14, 2023
Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
Journal: Gastroenterology
Published: September 15, 2022
Last Updated: 09/26/2026